Inside Capital Partners
Venture capitalEbene · Growth
Investment thesis
Inside Capital Partners positions itself as a new kind of partnership for health systems, seeking to deliver institutional venture-grade returns alongside direct operational impact within healthcare organizations. The teaser page cites illustrative performance targets, including a base-case MOIC of roughly 3.33x, a net IRR range of 23-29%, and EBITDA potential of about $73.4M per 1,000-bed system, signaling a healthcare-focused investment strategy tied to operational value creation in provider systems.
Source: firm website, verified Aug 3, 2026.
Frequently asked questions
- What stage does Inside Capital Partners invest at?
- Inside Capital Partners invests at the Growth stage.
- What sectors does Inside Capital Partners focus on?
- Inside Capital Partners focuses on Advanced Manufacturing, Consumer, Digital Health, Healthtech.
- Where is Inside Capital Partners located?
- Inside Capital Partners is headquartered in Ebene, MU.
Similar investors
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Giant Ventures is a venture capital firm investing across sectors including AI, climate, health, energy and fintech, and also incubates some of its own companies. Its portfolio spans roughly 48+ companies across the US and Europe.
Chiratae Ventures is an India-focused venture capital firm managing seven funds, with a portfolio of 136 companies and a track record of 56 exits and 5 IPOs.
AddVentures is the corporate venture capital arm of SCG, one of the largest industrial conglomerates in Southeast Asia. It engages with tech startups worldwide through partnerships and investments, leveraging SCG's network and resources across the region.
Cathay Health is an investment firm focused on companies at the intersection of life sciences, healthcare, and technology aiming to positively impact human health.